Related Experiment Video
Updated: Jul 17, 2026

Modeling Dysplastic and Functional Lung Alveolar Repair after Influenza Infection
Published on: September 19, 2025
The PB1-F2 protein of Influenza A virus: increasing pathogenicity by disrupting alveolar macrophages
1Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, NY 11794, USA. jrm.coleman@gmail.com
Abstract:
With the prospect of another pandemic Influenza fresh in our consciousness, the pathogenic nature of the Influenza A virus and its ability to induce high rates of mortality are ever more pertinent. Recently a novel protein encoded by an alternate reading frame in the PB1 Gene segment of Influenza A virus has been discovered and in turn shown to enhance viral virulence in a mouse model 1. This protein has been shown to specifically target and destroy alveolar macrophages 2. This review suggests that this protein, present in all previous pandemic strains, may reappear as a virulence factor in a subsequent pandemic strain. This PB1-F2 protein will enhance the mortality rate of the virus by increasing the likelihood of a secondary bacterial infection, which is the primary cause of death to a patient infected with Influenza A.
Insights
A newly discovered Influenza A protein, PB1-F2, enhances viral virulence and mortality by destroying alveolar macrophages. This protein may reappear in future pandemic strains, increasing the risk of deadly secondary bacterial infections.
Area of Science:
- Virology
- Immunology
- Pathogen Research
Background:
- Influenza A virus poses a significant pandemic threat due to its pathogenicity and mortality.
- A novel protein, PB1-F2, encoded by an alternate reading frame in the PB1 gene segment, has been identified.
- PB1-F2 has demonstrated an ability to enhance viral virulence in mouse models.
Discussion:
- This protein specifically targets and destroys alveolar macrophages, critical immune cells in the lungs.
- PB1-F2 has been present in all previous pandemic Influenza A strains.
- Its reappearance in a future pandemic strain could significantly increase the virus's virulence.
Key Insights:
- PB1-F2 enhances Influenza A virus pathogenicity by compromising the host's immune defenses.
- The destruction of alveolar macrophages by PB1-F2 is a key mechanism of increased virulence.
- Secondary bacterial infections, often fatal in Influenza A patients, are exacerbated by PB1-F2 activity.
Outlook:
- PB1-F2 represents a potential virulence factor for future Influenza A pandemics.
- Understanding PB1-F2's role is crucial for developing targeted antiviral strategies.
- Further research into PB1-F2 could inform pandemic preparedness and improve patient outcomes.
More Related Videos
Related Concept Videos
Leaky Scanning
Influenza
Inhibitors Of Virion Release
Pneumonia II: Pathophysiology
Inhalation Anthrax

